Minocycline attenuates post-operative cognitive impairment in aged mice by inhibiting microglia activation

Hui-Lin Wang1, Hua Liu2, Zhang-Gang Xue1

  • 1Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China.

Insights

Minocycline (MINO) pre-treatment protected aged mice from surgery or isoflurane-induced cognitive decline. MINO reduced neuroinflammation by inhibiting microglia activation, preserving spatial memory.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Gerontology

Background:

  • Post-operative cognitive dysfunction (POCD) is a common complication in aged individuals following anesthesia or surgery.
  • Current clinical interventions for POCD are limited, necessitating the exploration of novel therapeutic strategies.
  • Minocycline (MINO) has demonstrated neuroprotective effects in various models of neurodegenerative diseases.

Purpose of the Study:

  • To investigate the efficacy of Minocycline (MINO) pre-treatment in preventing isoflurane or surgery-induced cognitive impairment in aged mice.
  • To assess the impact of MINO on neuroinflammation markers in the hippocampus.
  • To evaluate the effect of MINO on spatial memory performance.

Main Methods:

  • Aged mice were pre-treated with Minocycline (MINO) before exposure to isoflurane or surgery.
  • Spatial memory was assessed using the Morris water maze task.
  • Hippocampal tissues were analyzed using Western blot, immunofluorescence, and protein array to measure inflammatory markers and microglial activation.

Main Results:

  • MINO pre-treatment significantly attenuated cognitive deficits in the Morris water maze.
  • MINO down-regulated the expression of pro-inflammatory cytokines (tumor necrosis factor-alpha, IL-1β, interferon-γ) and Iba-1 (microglia marker).
  • MINO up-regulated the expression of anti-inflammatory cytokines (IL-4, IL-10).

Conclusions:

  • Minocycline (MINO) pre-treatment effectively prevents isoflurane or surgery-induced cognitive impairment in aged mice.
  • The neuroprotective effects of MINO are mediated by the inhibition of microglial overactivation and reduction of neuroinflammation.
  • MINO represents a potential therapeutic agent for mitigating cognitive dysfunction in the elderly following surgical procedures or anesthesia.